BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 38133666)

  • 21. Adjuvant chemotherapy improves long-term survival in pathologic stage III rectal mucinous adenocarcinoma after pre-operative chemoradiotherapy.
    Liao H; Li T; Liang Y; Liu Y; Yuan Y; Li M; Li A; Liu Y; Yao Y; Li T
    Int J Colorectal Dis; 2023 Aug; 38(1):207. PubMed ID: 37542591
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Does IBD Portend Worse Outcomes in Patients with Rectal Cancer? A Case-Matched Analysis.
    Alsughayer A; Grass F; McKenna NP; Petersen M; Mathis KL; Lightner AL
    Dis Colon Rectum; 2020 Sep; 63(9):1265-1275. PubMed ID: 33216497
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Propensity-score matched analysis of the pathologic outcomes and survival benefits of neoadjuvant therapy in stage II-III anal adenocarcinoma.
    Emile SH; Horesh N; Garoufalia Z; Gefen R; Zhou P; Wexner SD
    J Surg Oncol; 2023 Sep; 128(4):585-594. PubMed ID: 37183543
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anastomotic leakage is associated with impaired overall and disease-free survival after curative rectal cancer resection: a propensity score analysis.
    Kulu Y; Tarantio I; Warschkow R; Kny S; Schneider M; Schmied BM; Büchler MW; Ulrich A
    Ann Surg Oncol; 2015; 22(6):2059-67. PubMed ID: 25348782
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Implications of Lymph Node Staging on Selection of Adjuvant Therapy for Gastric Cancer in the United States: A Propensity Score-matched Analysis.
    Datta J; McMillan MT; Ecker BL; Karakousis GC; Mamtani R; Plastaras JP; Giantonio BJ; Drebin JA; Dempsey DT; Fraker DL; Roses RE
    Ann Surg; 2016 Feb; 263(2):298-305. PubMed ID: 26135687
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic Value of Clinical vs Pathologic Stage in Rectal Cancer Patients Receiving Neoadjuvant Therapy.
    Delitto D; George TJ; Loftus TJ; Qiu P; Chang GJ; Allegra CJ; Hall WA; Hughes SJ; Tan SA; Shaw CM; Iqbal A
    J Natl Cancer Inst; 2018 May; 110(5):460-466. PubMed ID: 29165692
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of Postoperative Chemoradiotherapy versus Chemotherapy Alone on Recurrence and Survival in Patients with Stage II and III Upper Rectal Cancer: A Propensity Score-Matched Analysis.
    Song C; Song S; Kim JS; Oh HK; Kim DW; Lee KW; Kim JH; Eom KY; Kim IA; Kang SB
    PLoS One; 2015; 10(4):e0123657. PubMed ID: 25902069
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adjuvant chemotherapy does not improve cancer-specific survival for pathologic stage II/III rectal adenocarcinoma after neoadjuvant chemoradiotherapy and surgery: evidence based on long-term survival analysis from SEER data.
    Liao H; Zeng T; Xie X; Li J; Li D; KejinYan ; Chen F; Zhu H
    Int J Colorectal Dis; 2023 May; 38(1):134. PubMed ID: 37199862
    [TBL] [Abstract][Full Text] [Related]  

  • 29. mFOLFOXIRI versus mFOLFOX6 as neoadjuvant chemotherapy in locally advanced rectal cancer: A Propensity Score Matching Analysis.
    Ding M; Zhang J; Hu H; Cai Y; Ling J; Wu Z; Xie X; Li J; Li W; Deng Y
    Clin Colorectal Cancer; 2022 Mar; 21(1):e12-e20. PubMed ID: 34963563
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adjuvant Chemotherapy Is Associated With Improved Overall Survival in Locally Advanced Rectal Cancer After Achievement of a Pathologic Complete Response to Chemoradiation.
    Shahab D; Gabriel E; Attwood K; Ma WW; Francescutti V; Nurkin S; Boland PM
    Clin Colorectal Cancer; 2017 Dec; 16(4):300-307. PubMed ID: 28420585
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of health insurance status with presentation, treatment and outcomes in soft tissue sarcoma.
    Jain V; Venigalla S; Sebro RA; Karakousis GC; Wilson RJ; Weber KL; Shabason JE
    Cancer Med; 2019 Oct; 8(14):6295-6304. PubMed ID: 31483578
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surgical outcomes and predictors of overall survival of stage I-III appendiceal adenocarcinoma: Retrospective cohort analysis of the national cancer database.
    Emile SH; Horesh N; Freund MR; Silva-Alvarenga E; Garoufalia Z; Gefen R; Wexner SD
    Surg Oncol; 2024 Feb; 52():102034. PubMed ID: 38211448
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Survival and prognostic factors in patients with rectal squamous cell carcinoma.
    Kommalapati A; Tella SH; Yadav S; Goyal G; Hallemeier C; Durgin L; Jin Z; Mahipal A
    Eur J Surg Oncol; 2020 Jun; 46(6):1111-1117. PubMed ID: 32201124
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Refining the Use of Adjuvant Oxaliplatin in Clinical Stage II or III Rectal Adenocarcinoma.
    Margalit O; Mamtani R; Kopetz S; Yang YX; Lawrence YR; Abu-Gazala S; Reiss KA; Golan T; Halpern N; Aderka D; Giantonio B; Shacham-Shmueli E; Boursi B
    Oncologist; 2019 Aug; 24(8):e671-e676. PubMed ID: 30696723
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adjuvant Chemotherapy After Preoperative Chemoradiation Improves Survival in Patients With Locally Advanced Rectal Cancer.
    Sun Z; Gilmore B; Adam MA; Kim J; Hsu SD; Migaly J; Mantyh CR
    Dis Colon Rectum; 2017 Oct; 60(10):1050-1056. PubMed ID: 28891848
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neoadjuvant chemoradiotherapy might provide survival benefit in patients with stage IIIb/IIIc locally advanced rectal cancer: A retrospective single-institution study with propensity score-matched comparative analysis.
    Sun XY; Cai SH; Xu L; Luo D; Qiu HZ; Wu B; Lin GL; Lu JY; Zhang GN; Xiao Y
    Asia Pac J Clin Oncol; 2020 Jun; 16(3):142-149. PubMed ID: 32031326
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Different Impacts of Preoperative Radiotherapy and Chemoradiotherapy on Oncological Outcomes in Patients with Stages II and III Lower Rectal Cancer: A Propensity Score Analysis.
    Takiyama H; Kawai K; Ishihara S; Yasuda K; Otani K; Nishikawa T; Tanaka T; Kiyomatsu T; Hata K; Nozawa H; Morikawa T; Watanabe T
    Dig Surg; 2018; 35(3):212-219. PubMed ID: 28637039
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of Timing of Adjuvant Therapy With Survival in Patients With Resected Stage I to II Pancreatic Cancer.
    Ma SJ; Oladeru OT; Miccio JA; Iovoli AJ; Hermann GM; Singh AK
    JAMA Netw Open; 2019 Aug; 2(8):e199126. PubMed ID: 31411712
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Definitive Chemoradiation for Rectal Cancer: Is There a Role for Dose Escalation? A National Cancer Database Study.
    Wegner RE; Hasan S; Renz PB; Raj MS; Monga DK; Finley GG; Kirichenko AV; McCormick JT
    Dis Colon Rectum; 2019 Nov; 62(11):1336-1343. PubMed ID: 31567930
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Survival and prognostic factors in patients with pancreatic squamous cell carcinoma.
    Tella SH; Kommalapati A; Yadav S; Bergquist JR; Truty MJ; Durgin L; Ma WW; Cleary SP; McWilliams RR; Mahipal A
    Eur J Surg Oncol; 2019 Sep; 45(9):1700-1705. PubMed ID: 31118133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.